NO20034185D0 - Nikotinreseptorantagonister for behandling av inflammatoriske sykdommer - Google Patents
Nikotinreseptorantagonister for behandling av inflammatoriske sykdommerInfo
- Publication number
- NO20034185D0 NO20034185D0 NO20034185A NO20034185A NO20034185D0 NO 20034185 D0 NO20034185 D0 NO 20034185D0 NO 20034185 A NO20034185 A NO 20034185A NO 20034185 A NO20034185 A NO 20034185A NO 20034185 D0 NO20034185 D0 NO 20034185D0
- Authority
- NO
- Norway
- Prior art keywords
- agonists
- pulmonary
- nicotine receptor
- diseases
- inflammatory diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002341952A CA2341952A1 (en) | 2001-03-23 | 2001-03-23 | Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases |
PCT/CA2002/000412 WO2002076434A2 (en) | 2001-03-23 | 2002-03-25 | Nicotinic receptor agonists for the treatment of inflammatory diseases |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20034185D0 true NO20034185D0 (no) | 2003-09-19 |
NO20034185L NO20034185L (no) | 2003-11-24 |
NO331674B1 NO331674B1 (no) | 2012-02-20 |
Family
ID=4168679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20034185A NO331674B1 (no) | 2001-03-23 | 2003-09-19 | Farmasoytisk sammensetning omfattende nikotinreseptorantagonist for lindring eller forebygging av pulmonaer inflammatorisk sykdom |
Country Status (18)
Country | Link |
---|---|
US (3) | US7601720B2 (no) |
EP (1) | EP1370264B1 (no) |
JP (1) | JP4377586B2 (no) |
CN (1) | CN100528159C (no) |
AT (1) | ATE378051T1 (no) |
AU (1) | AU2002249023B2 (no) |
BR (1) | BR0208305A (no) |
CA (1) | CA2341952A1 (no) |
DE (1) | DE60223508T2 (no) |
DK (1) | DK1370264T3 (no) |
ES (1) | ES2295331T3 (no) |
IL (1) | IL157757A0 (no) |
MX (1) | MXPA03008423A (no) |
NO (1) | NO331674B1 (no) |
NZ (1) | NZ528042A (no) |
PL (1) | PL207880B1 (no) |
RU (1) | RU2299731C2 (no) |
WO (1) | WO2002076434A2 (no) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8188043B2 (en) | 1999-07-28 | 2012-05-29 | The Board Of Trustees Of The Leland Stanford Jr. University | Nicotine in therapeutic angiogenesis and vasculogenesis |
CA2341952A1 (en) | 2001-03-23 | 2002-09-23 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases |
US20050130990A1 (en) * | 2001-03-23 | 2005-06-16 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
US7045534B2 (en) * | 2002-02-12 | 2006-05-16 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of reducing angiogenesis |
US8039459B2 (en) | 2004-07-15 | 2011-10-18 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
US8557804B2 (en) | 2002-03-25 | 2013-10-15 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
US20040010018A1 (en) * | 2002-05-15 | 2004-01-15 | Rueter Lynne E. | Treatment of neuropathic pain |
US7238715B2 (en) | 2002-12-06 | 2007-07-03 | The Feinstein Institute For Medical Research | Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists |
PL364348A1 (en) | 2004-01-12 | 2005-07-25 | PHARMENA Sp.z o.o. | Application of quaternary pyridine salts as vessel protection agent |
NZ553211A (en) * | 2004-07-15 | 2010-11-26 | Univ Laval | Nicotinic receptor agonists for the treatment of pulmonary inflammatory diseases |
US8378109B2 (en) | 2004-12-07 | 2013-02-19 | The Regents Of The University Of California | Labeled ALPHA4BETA2 ligands and methods therefor |
US9029557B2 (en) | 2004-12-07 | 2015-05-12 | The Regents Of The University Of California | Labeled A4B2 ligands and methods therefor |
US8316104B2 (en) | 2005-11-15 | 2012-11-20 | California Institute Of Technology | Method and apparatus for collaborative system |
JP2009519962A (ja) * | 2005-12-19 | 2009-05-21 | コメンティス,インコーポレーテッド | 眼投与用局所メカミルアミン製剤およびその使用 |
WO2007129879A1 (es) * | 2006-05-08 | 2007-11-15 | Arturo Solis Herrera | EL USO DE LA NICOTINA, SUS ANÁLOGOS, SUS PRECURSORES O SUS DERIVADOS EN EL TRATAMIENTO DE DIVERSOS PROCESOS PATOLÓGICOS SUSCEPTIBLES DE MEJORAR CON α-MSH ADMINISTRADA EN FORMA PROFILÁCTICA O TERAPÉUTICA. |
EP3524245A1 (en) * | 2010-03-23 | 2019-08-14 | Philip Morris Products S.A. | Use of anatabine to treat inflammation and methods of synthesizing anatabine |
US8207346B2 (en) | 2010-03-23 | 2012-06-26 | Rock Creek Pharmaceuticals, Inc. | Methods of synthesizing anatabine |
JP5934796B2 (ja) | 2011-08-29 | 2016-06-15 | アールシーピー ディベロップメント インコーポレイテッド | 抗炎症補助のための製品 |
EP3125903B1 (en) | 2014-04-03 | 2018-12-19 | Université Laval | Method for use of homopiperazinium compounds in the treatment of cancer |
RU2593585C1 (ru) * | 2015-06-26 | 2016-08-10 | Общество с ограниченной ответственностью "Ритек-Фарма" | Способ лечения табакокурения и других форм никотиновой зависимости, а также профилактики рецидивов табакокурения |
CN113992687B (zh) * | 2021-12-28 | 2022-04-08 | 浙江宇视科技有限公司 | 智能业务集群调度方法、装置、电子设备及存储介质 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2594296A (en) * | 1948-06-24 | 1952-04-29 | Aerosol Corp | Lobeline aerosol dilating medicament |
US2778772A (en) * | 1952-11-04 | 1957-01-22 | Parke Davis & Co | Dimethyl phenyl piperazinium iodide compositions and process for stimulation of the autonomic ganglion system |
US3402039A (en) * | 1966-12-05 | 1968-09-17 | Dow Chemical Co | Piperazinium salts as plant stunting agents |
US5977144A (en) * | 1992-08-31 | 1999-11-02 | University Of Florida | Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines |
US5856480A (en) * | 1994-11-11 | 1999-01-05 | Nippon Soda Co., Ltd. | Optically active compound |
WO2000023062A2 (en) * | 1998-10-20 | 2000-04-27 | Omeros Medical Systems, Inc. | Irrigation solution and method for inhibition of pain and inflammation |
US5846983A (en) | 1996-02-09 | 1998-12-08 | Mayo Foundation For Medical Education And Research | Colonic delivery of nicotine to treat inflammatory bowel disease |
RU2127123C1 (ru) * | 1996-06-04 | 1999-03-10 | Московское производственное химико-фармацевтическое объединение им.Н.А.Семашко | Противоастматическое лекарственное средство в виде таблеток и способ получения таблеток |
GB9614902D0 (en) * | 1996-07-16 | 1996-09-04 | Rhodes John | Sustained release composition |
US5981549A (en) * | 1997-02-14 | 1999-11-09 | Synapse Pharmaceutical International | Method for controlling or alleviating the symptoms of respiratory disease and allergies |
WO1999021834A1 (en) | 1997-10-27 | 1999-05-06 | Neurosearch A/S | Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
CA2364026C (en) * | 1999-03-02 | 2012-08-21 | Centocor, Inc. | Anti-tnf.alpha. antibodies in therapy of asthma |
JP2003502374A (ja) * | 1999-06-21 | 2003-01-21 | ブリストルーマイヤーズ スクイブ カンパニー | Npy拮抗薬としてのジヒドロピラジン誘導体 |
SE0001075D0 (sv) * | 1999-09-01 | 2000-03-27 | Laszlo Bense | Användning av åtminstone ett nikotinbaserat ämne och/eller ett ur detta ämne framställt ämne för tillverkning av ett medikament samt förfarande för behandling av obstruktiva lungsjukdomar |
GB0008660D0 (en) * | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
US6610713B2 (en) * | 2000-05-23 | 2003-08-26 | North Shore - Long Island Jewish Research Institute | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
JP2004514722A (ja) * | 2000-12-01 | 2004-05-20 | ニューロサーチ、アクティーゼルスカブ | 3−置換されたキヌクリジン及びこれをニコチンアンタゴニストとして使用する方法 |
US20020160988A1 (en) * | 2001-02-20 | 2002-10-31 | Israel Institute For Biological Research | Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
WO2002076424A1 (en) | 2001-03-22 | 2002-10-03 | Battelle Memorial Institute | Liquid formations for electrohydrodymanic spraying containing polymer and suspended particles |
CA2341952A1 (en) | 2001-03-23 | 2002-09-23 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases |
US20050130990A1 (en) * | 2001-03-23 | 2005-06-16 | Universite Laval | Nicotinic receptor agonists for the treatment of inflammatory diseases |
US6667344B2 (en) * | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
GB2381750A (en) | 2001-10-10 | 2003-05-14 | Inspire Pharmaceuticals Inc | Treatment for enhancing joint lubrication |
US20030236287A1 (en) * | 2002-05-03 | 2003-12-25 | Piotrowski David W. | Positive allosteric modulators of the nicotinic acetylcholine receptor |
TW200412945A (en) * | 2002-10-25 | 2004-08-01 | Upjohn Co | Quaternary ammonium compounds |
CA2498189A1 (en) * | 2002-10-29 | 2004-05-13 | Pharmacia & Upjohn Company Llc | Quaternary ammonium compounds |
JP2006506392A (ja) * | 2002-10-29 | 2006-02-23 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | ムスカリン受容体アンタゴニストとしての第四級アンモニウム化合物 |
US20050075323A1 (en) * | 2003-03-05 | 2005-04-07 | Pfizer Inc | Beta3 adrenergic receptor agonists and uses thereof |
FR2852830B1 (fr) | 2003-03-24 | 2008-04-18 | Oreal | Composition de teinture des fibres keratiniques comprenant un derive de para-phenylenediamine cationique substitue par un cycle diazacyclohexane ou diazacycloheptane |
MXPA05011059A (es) * | 2003-04-15 | 2005-12-12 | Pharmacia & Upjohn Co Llc | Compuestos de amonio cuaternario y su uso como agentes antimuscarinicos. |
NZ553211A (en) | 2004-07-15 | 2010-11-26 | Univ Laval | Nicotinic receptor agonists for the treatment of pulmonary inflammatory diseases |
-
2001
- 2001-03-23 CA CA002341952A patent/CA2341952A1/en not_active Abandoned
-
2002
- 2002-03-25 JP JP2002574950A patent/JP4377586B2/ja not_active Expired - Fee Related
- 2002-03-25 BR BR0208305-1A patent/BR0208305A/pt not_active IP Right Cessation
- 2002-03-25 WO PCT/CA2002/000412 patent/WO2002076434A2/en active IP Right Grant
- 2002-03-25 AU AU2002249023A patent/AU2002249023B2/en not_active Ceased
- 2002-03-25 PL PL365224A patent/PL207880B1/pl unknown
- 2002-03-25 RU RU2003131178/14A patent/RU2299731C2/ru not_active IP Right Cessation
- 2002-03-25 DE DE60223508T patent/DE60223508T2/de not_active Expired - Lifetime
- 2002-03-25 EP EP02717896A patent/EP1370264B1/en not_active Expired - Lifetime
- 2002-03-25 AT AT02717896T patent/ATE378051T1/de active
- 2002-03-25 ES ES02717896T patent/ES2295331T3/es not_active Expired - Lifetime
- 2002-03-25 NZ NZ528042A patent/NZ528042A/en not_active IP Right Cessation
- 2002-03-25 MX MXPA03008423A patent/MXPA03008423A/es active IP Right Grant
- 2002-03-25 DK DK02717896T patent/DK1370264T3/da active
- 2002-03-25 US US10/469,999 patent/US7601720B2/en not_active Expired - Fee Related
- 2002-03-25 IL IL15775702A patent/IL157757A0/xx not_active IP Right Cessation
- 2002-03-25 CN CNB028071387A patent/CN100528159C/zh not_active Expired - Fee Related
-
2003
- 2003-09-19 NO NO20034185A patent/NO331674B1/no not_active IP Right Cessation
-
2009
- 2009-09-03 US US12/553,574 patent/US20100227871A1/en not_active Abandoned
-
2011
- 2011-06-15 US US13/161,035 patent/US8377936B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE378051T1 (de) | 2007-11-15 |
CN1498108A (zh) | 2004-05-19 |
DK1370264T3 (da) | 2008-03-17 |
EP1370264A2 (en) | 2003-12-17 |
US20100227871A1 (en) | 2010-09-09 |
NZ528042A (en) | 2005-10-28 |
PL207880B1 (pl) | 2011-02-28 |
BR0208305A (pt) | 2004-03-09 |
ES2295331T3 (es) | 2008-04-16 |
MXPA03008423A (es) | 2004-03-19 |
IL157757A0 (en) | 2004-03-28 |
CN100528159C (zh) | 2009-08-19 |
EP1370264B1 (en) | 2007-11-14 |
NO331674B1 (no) | 2012-02-20 |
RU2003131178A (ru) | 2005-04-10 |
WO2002076434A2 (en) | 2002-10-03 |
US20110245270A1 (en) | 2011-10-06 |
PL365224A1 (en) | 2004-12-27 |
NO20034185L (no) | 2003-11-24 |
US7601720B2 (en) | 2009-10-13 |
CA2341952A1 (en) | 2002-09-23 |
JP2004523588A (ja) | 2004-08-05 |
RU2299731C2 (ru) | 2007-05-27 |
US8377936B2 (en) | 2013-02-19 |
US20040132737A1 (en) | 2004-07-08 |
WO2002076434A3 (en) | 2003-07-17 |
DE60223508D1 (de) | 2007-12-27 |
AU2002249023B2 (en) | 2006-02-02 |
DE60223508T2 (de) | 2008-09-25 |
JP4377586B2 (ja) | 2009-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20034185L (no) | Nikotinreseptorantagonister for behandling av inflammatoriske sykdommer | |
DE60120936D1 (de) | Behandlung von atemerkrankungen | |
ATE330589T1 (de) | Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege | |
JP2017528507A5 (no) | ||
EA200702387A1 (ru) | Имидазохинолины в качестве ингибиторов липидкиназы | |
WO2004041183A3 (en) | Methods of treating pulmonary fibrotic disorders | |
NO20072466L (no) | Fremgangsmate for a forhindre og behandle strukturendring i luftveier og pulmonal inflammasjon ved a anvende A2B-adenosinreseptorantagonister | |
MXPA03010731A (es) | Combinacion de agonista del receptor a2a de adenosina y tiotropio o sus derivados para tratar enfermedades obstructivas de vias aereas. | |
WO2005107726A3 (en) | Method for the treatment of back pain | |
SG169233A1 (en) | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation | |
EP2269610A3 (en) | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors | |
WO2005000298A3 (en) | 5-membered heterocycle-based p-38 inhibitors | |
TW200738729A (en) | Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia | |
MX2021014157A (es) | Formas cristalinas de un inhibidor btk. | |
NO20074084L (no) | Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikamenter og medikamenter inneholdende disse | |
BR0313718A (pt) | Composto, processo para a preparação do mesmo, composição farmacêutica, métodos para tratar um indivìduo humano ou animal sofrendo de uma condição que é mediada por cox-2 e para tratar um indivìduo humano ou animal sofrendo de um distúrbio inflamatório, e, uso de um composto | |
WO2006012640A3 (en) | Method of administration of dopamine receptor agonists | |
JP2017536380A5 (no) | ||
JOP20200314A1 (ar) | تركيبات صيدلانية مستقرة لأجهزة إستنشاق جرعات مضغوطة معايرة الجرعة | |
UY30935A1 (es) | Combinacion:-antagonista del receptor de quimioquina 1 (ccr1) -agonista del receptor de glucocorticoides- opcionalmente agonista b(beta)2, -composicion farmacéutica conteniéndola -aplicaciones. | |
WO2004056310A3 (en) | Methods of diagnosis and treatment of interstitial lung disease | |
EA200200518A1 (ru) | Способ и композиция для лечения заболеваний легких | |
HUP0401967A2 (hu) | Nikotinsav-acetilkolin-receptor-agonisták alkalmazása nyugtalan láb szindróma kezelésére alkalmas gyógyszerkészítmények előállítására | |
JP2007506726A5 (no) | ||
MX2023005801A (es) | Derivados de ftalazina como inhibidores de purinoceptor 3 de p2x (p2x3). |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |